Skip to main content

Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway

The Original Article was published on 05 February 2021

Retraction Note to: Stem Cell Research & Therapy (2021) 12:115 https://doi.org/10.1186/s13287-021-02183-2

The authors have retracted this article. After publication the authors became aware of issues with two of the figures, specifically:

  • In Fig. 5c the echocardiography images for 1 week and 3 weeks for the MI + HG group had been duplicated owing to an error in the assembly of the figure.

  • In Fig. 3a the bands for Beclin 1 had been constructed by using the bands from P21 in Fig. 2e during assembly of the figure.

All authors agree with this retraction.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zhuoqi Zhang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, F., Gao, F., Wang, K. et al. Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway. Stem Cell Res Ther 12, 529 (2021). https://doi.org/10.1186/s13287-021-02606-0

Download citation